Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Contributed by: PR Newswire

Tags

Cepheid-Partners

More Like This

Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

UK to create world-first 'early warning system' for pandemics

Apple showcases Oxford Nanopore in M3 launch

From left to right: Dr. Iri Sato Baran, Genesis Healthcare (A.D.A.M Innovations), Vice Chair of the Board Ambassador Julia Longbottom, British Embassy Foreign, Commonwealth and Development Office Michel Mommejat, Genesis Healthcare (A.D.A.M Innovations), CEO and Executive Director Gretchen Weightman, Oxford Nanopore Technologies, Senior Vice President Commercial and General Manager APAC, Dr. Toshiharu Furukawa, LDP, Chair of Medical Information Policy and Genomic Medicine, House of Councillors, Hirokazu Shimoda, Japan Agency for Medical Research and Development, Senior Director

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and WeNou Announce a Partnership to Develop and Commercialise the First Rapid and Portable Food Authenticity Sequencing Test to Detect Food Fraud

Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing Service

PR Newswire associated0

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing